Ally Financial’s Edwards Lifesciences EW Stock Holding History

Ally Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.24M	Hold	26,000	–	–	0.31%	78
2026 Q2	$2.35M	Buy	26,000 +13,000	+100%	+$1.09M	0.3%	83
2026 Q1	$1.04M	Buy	+13,000	New	+$1.07M	0.13%	109
2025 Q2	–	Sell	-15,000	Closed	-$1.09M	–	110
2025 Q1	$1.09M	Hold	15,000	–	–	0.12%	95
2024 Q4	$1.11M	Hold	15,000	–	–	0.14%	89
2024 Q3	$990K	Buy	+15,000	New	+$1.09M	0.12%	98
2024 Q2	–	Sell	-6,000	Closed	-$573K	–	119
2024 Q1	$573K	Hold	6,000	–	–	0.08%	104
2023 Q4	$458K	Hold	6,000	–	–	0.06%	98
2023 Q3	$416K	Buy	+6,000	New	+$482K	0.06%	105
2014 Q2	–	Sell	-210,000	Closed	-$2.6M	–	132
2014 Q1	$2.6M	Buy	210,000 +150,000	+250%	+$1.73M	0.28%	118
2013 Q4	$658K	Buy	+60,000	New	+$676K	0.07%	121

Other funds holding EW

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Ally Financial's EW Position: Q3 2026 in Review

Ally Financial held its Edwards Lifesciences (EW) position steady in Q3 2026 at 26,000 shares worth $2.24M. The position accounts for 0.31% of the portfolio, ranked #78.

Ally Financial first reported a position in EW in Q4 2013 and has held it in 11 quarters since. The position peaked at $2.6M in Q1 2014. 980 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Ally Financial held 26,000 shares of Edwards Lifesciences worth $2.24M as of Q3 2026.
Ally Financial left its Edwards Lifesciences share count unchanged in Q3 2026.
Edwards Lifesciences made up 0.31% of Ally Financial's portfolio in Q3 2026, its #78 holding.
Ally Financial first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 11 quarters since.
Ally Financial's Edwards Lifesciences position peaked at $2.6M in Q1 2014.
980 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Ally Financial's 13F filing for Q3 2026, filed 12 Nov 2026.